| 2023 | Age, Sex, and Body Mass Index Should Be Considered When Assessing Spleen Length in Patients with Compensated Advanced Chronic Liver Disease | 이한아 | Article |
| 2024 | Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation | 이한아 | Article |
| 2023 | Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis | 이한아 | Article |
| 2022 | Endoscopic variceal obturation and retrograde transvenous obliteration for acute gastric cardiofundal variceal bleeding in liver cirrhosis | 이한아 | Article |
| 2022 | Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients | 이한아 | Article |
| 2024 | High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study | 이한아 | Article |
| 2023 | Impact of Low Skeletal Muscle Mass on Long-Term Outcomes in Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization: A Retrospective Multi-Center Study | 이한아 | Article |
| 2024 | Increased spine bone density in patients with chronic hepatitis B switched to tenofovir alafenamide: A prospective, multinational study | 이한아 | Article |
| 2023 | Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study | 이한아 | Article |
| 2023 | Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase | 이한아 | Article |
| 2023 | Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future | 이한아 | Review |
| 2023 | The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNA | 이한아 | Article |
| 2022 | Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases | 이한아 | Review |
| 2023 | Transarterial chemoembolization for hepatocellu- lar carcinoma: 2023 Expert consensus-based prac- tical recommendations of the Korean Liver Cancer Association | 이한아 | Article |
| 2023 | Transarterial Chemoembolization for Hepatocellular Carcinoma: 2023 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association | 이한아 | Article |
| 2023 | Transarterial radioembolization versus tyrosine ki- nase inhibitor in hepatocellular carcinoma with portal vein thrombosis | 이한아 | Article |
